WRX-10568-91555
4 vaccinations
3 coded responses
43 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 800 / CO
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Thirst — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Sore throat, Frequently thirstyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-07-24
- 2021-10-25
-
2021-11-15
Dose 3 — Pfizer-BioNTech
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-02-14
- 2022-05-16
-
2022-09-08
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-29
- 2022-10-06
- 2022-10-13
-
2022-12-08
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: GoodFree text: Mild cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: COVID-19, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-09
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-09 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat, Frequently thirsty
Release 12 — 3 months, dose 4
Symptoms: Mild cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Thirst | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release